Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists
Toll-like receptor 7 (TLR7) is activated in response to the binding of single-stranded RNA. Its over-activation has been implicated in several autoimmune disorders, and thus, it is an established therapeutic target in such circumstances. TLR7 small-molecule antagonists are not yet available for ther...
Main Authors: | Sourav Pal, Uddipta Ghosh Dastidar, Trisha Ghosh, Dipyaman Ganguly, Arindam Talukdar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/13/4026 |
Similar Items
-
Recent Advances on Small-Molecule Antagonists Targeting TLR7
by: Haoyang Zheng, et al.
Published: (2023-01-01) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
by: Amani E. Khalifa, PhD, et al.
Published: (2021-01-01) -
Predictive Modeling of Antioxidant Coumarin Derivatives Using Multiple Approaches: Descriptor-Based QSAR, 3D-Pharmacophore Mapping, and HQSAR
by: Indrani MITRA, et al.
Published: (2016-09-01) -
Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents
by: Jinxin Che, et al.
Published: (2018-01-01) -
Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors
by: Anushka A. Poola, et al.
Published: (2023-02-01)